This is Bob Garfield with an OTM podcast extra in about 60 seconds. Look, the production of On the

media has never been cheap or easy. Now the process is crazy and expensiveer too. Now more than

ever. As they say, we need listeners' financial support.

Obviously, many of you are absolutely strapped at the moment, and we surely expect you to sit this one out,

but that only increases the need for everyone else to step up.

Please support OTM when we and you need it most. Go to onemedia.org and hit

donate or text OTM to 70101. Thank you.

Gosh, can this really be from only a month ago?

What do you have to lose?

Take it.

I really think they should take it.

But it's their choice, and it's the doctor's choice or the doctors in the hospital.

But hydroxychloroquine, try it. There's more than ample evidence that hydroxychloroquine saves lives, speeds up recovery time, and cuts down on hospitalizations. It's also one of the

safer drugs out there just by virtue of the fact that it's been around for what, 65 years?

Yes, amid a panic to find a treatment for COVID-19,

certain politicians and certain corners of the media

fell in love with a drug proven a few weeks later

to present mortal risks outweighing any potential efficacy.

This is what happens when hope triumphs over caution. The hydroxychloroquine

debacle should have been a lesson learned, but now comes the bandwagon for the antiviral

drug, Remdesivir. Gilead, the biopharmaceutical company behind the experimental drug, today

reveals significant positive results in

...